Top

Published in:

Open Access 01-03-2011 | Review

Advances of genomic science and systems biology in renal transplantation: a review

Authors: David Perkins, Meenakshi Verma, Ken J. Park

Published in: Seminars in Immunopathology | Issue 2/2011

Abstract

The diagnosis of rejection in kidney transplant patients is based on histologic classification of a graft biopsy. The current “gold standard” is the Banff 97 criteria; however, there are several limitations in classifying rejection based on biopsy samples. First, a biopsy involves an invasive procedure. Second, there is significant variance among blinded pathologists in the interpretation of a biopsy. And third, there is also variance between the histology and the molecular profiles of a biopsy. To increase the positive predictive value of classifiers of rejection, a Banff committee is developing criteria that integrate histologic and molecular data into a unified classifier that could diagnose and prognose rejection. To develop the most appropriate molecular criteria, there have been studies by multiple groups applying omics technologies in attempts to identify biomarkers of rejection. In this review, we discuss studies using genome-wide data sets of the transcriptome and proteome to investigate acute rejection, chronic allograft dysfunction, and tolerance. We also discuss studies which focus on genetic biomarkers in urine and peripheral blood, which will provide clinicians with minimally invasive methods for monitoring transplant patients. We also discuss emerging technologies, including whole-exome sequencing and RNA-Seq and new bioinformatic and systems biology approaches, which should increase the ability to develop both biomarkers and mechanistic understanding of the rejection process.

Solez K (2010) History of the Banff classification of allograft pathology as it approaches its 20th year. Curr Opin Organ Transplant 15:49–51PubMedCrossRef

Racusen LC et al (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713–723PubMedCrossRef

Veronese FV et al (2005) Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin Transplant 19:518–521PubMedCrossRef

Gough J et al (2002) Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. Nephrol Dial Transplant 17:1081–1084PubMedCrossRef

Howie AJ (2002) Problems with BANFF. Transplantation 73:1383–1384PubMedCrossRef

Matoza JR, Danguilan RA, Chicano S (2008) Impact of Banff borderline acute rejection among renal allograft recipients. Transplant Proc 40:2303–2306PubMedCrossRef

Solez K et al (2008) Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8:753–760PubMedCrossRef

Sis B et al (2010) Banff ’09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Trans 10:464–471CrossRef

Venter JC et al (2001) The sequence of the human genome. Science 291:1304–1351PubMedCrossRef

10.

Lander ES et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921PubMedCrossRef

11.

U.S. Renal Data System, USRDS (2010) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD

12.

Weintraub LA, Sarwal MM (2006) Microarrays: a monitoring tool for transplant patients? Transpl Int 19:775–788PubMedCrossRef

13.

Barnes M, Freudenberg J, Thompson S, Aronow B, Pavlidis P (2005) Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Nucleic Acids Res 33:5914–5923PubMedCrossRef

14.

Shi L et al (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151–1161PubMedCrossRef

15.

Stoeckert CJ Jr, Causton HC, Ball CA (2002) Microarray databases: standards and ontologies. Nat Genet 32(Suppl):469–473PubMedCrossRef

16.

Quackenbush J (2002) Microarray data normalization and transformation. Nat Genet 32(Suppl):496–501PubMedCrossRef

17.

Sarwal M et al (2001) Genomic analysis of renal allograft dysfunction using cDNA microarrays. Transplant Proc 33:297–298PubMedCrossRef

18.

Famulski KS et al (2006) Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts. Am J Transplant 6:1342–1354PubMedCrossRef

19.

Batirel HF, Batirel S, Mitchell RN, Swanson SJ (2005) Interferon-gamma knockout fails to confer protection against obliteration in heterotopic murine tracheal allografts. J Heart Lung Transplant 24:658–664PubMedCrossRef

20.

Hidalgo LG et al (2008) The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant 8:637–646PubMedCrossRef

21.

Mueller TF et al (2007) Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 7:2712–2722PubMedCrossRef

22.

http://www.ncbi.nlm.nih.gov/geo/info/GEOHandoutFinal.pdf. Accesed on November 10, 2010

23.

Hamid, JS et al. (2009) Data integration in genetics and genomics: methods and challenges. Hum Genomics Proteomics

24.

Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550PubMedCrossRef

25.

Morgan AA, Khatri P, Jones RH, Sarwal MM, Butte AJ (2010) Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplants. BMC Bioinformatics 11(Suppl 9):S6PubMedCrossRef

26.

Saint-Mezard P et al (2009) Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transpl Int 22:293–302PubMedCrossRef

27.

Nakorchevsky A et al (2010) Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol 21:362–373PubMedCrossRef

28.

Kainz A et al (2007) Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function. Transplantation 83:1048–1054PubMedCrossRef

29.

Scherer A et al (2009) Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IFTA) at 6 months. Nephrol Dial Transplant 24:2567–2575PubMedCrossRef

30.

Rodder S et al (2009) Renal allografts with IFTA display distinct expression profiles of metzincins and related genes. Am J Transplant 9:517–526PubMedCrossRef

31.

Kurian SM et al (2009) Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS ONE 4:e6212PubMedCrossRef

32.

Flechner SM et al (2004) Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 4:1475–1489PubMedCrossRef

33.

Gunther OP et al (2009) Functional genomics analysis of peripheral blood during early acute renal allograft rejection. Transplantation 88:942–951PubMedCrossRef

34.

Horwitz PA et al (2004) Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110:3815–3821PubMedCrossRef

35.

Deng MC et al (2006) Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6:150–160PubMedCrossRef

36.

Fang KC (2007) Clinical utilities of peripheral blood gene expression profiling in the management of cardiac transplant patients. J Immunotoxicol 4:209–217PubMedCrossRef

37.

Sigdel TK et al (2010) Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl 4:32–47PubMedCrossRef

38.

Brouard S et al (2007) Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 104:15448–15453PubMedCrossRef

39.

Braud C et al (2008) Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis. J Cell Biochem 103:1681–1692PubMedCrossRef

40.

Newell KA et al (2010) Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120:1836–1847PubMedCrossRef

41.

Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19:212–219PubMedCrossRef

42.

Frazer KA, Murray SS, Schork NJ, Topol EJ (2009) Human genetic variation and its contribution to complex traits. Nat Rev Genet 10:241–251PubMedCrossRef

43.

Cirulli ET et al (2010) Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol 11:R57PubMed

44.

Choi M et al (2009) Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA 106:19096–19101PubMedCrossRef

45.

Werner T (2010) Next generation sequencing in functional genomics. Brief Bioinform 11:499–511PubMedCrossRef

46.

Grigoryev YA et al (2009) Genome-wide analysis of immune activation in human T and B cells reveals distinct classes of alternatively spliced genes. PLoS ONE 4:e7906PubMedCrossRef

47.

Lee E, Chuang HY, Kim JW, Ideker T, Lee D (2008) Inferring pathway activity toward precise disease classification. PLoS Comput Biol 4:e1000217PubMedCrossRef

48.

Beyer A, Bandyopadhyay S, Ideker T (2007) Integrating physical and genetic maps: from genomes to interaction networks. Nat Rev Genet 8:699–710PubMedCrossRef

49.

Ogata Y et al (2009) The prediction of local modular structures in a co-expression network based on gene expression datasets. Genome Inform 23:117–127PubMedCrossRef

Title: Advances of genomic science and systems biology in renal transplantation: a review
Authors: David Perkins
Meenakshi Verma
Ken J. Park
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: Seminars in Immunopathology / Issue 2/2011
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-011-0243-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Special issues in the management and selection of the donor for lung transplantation

Regulatory T cells in lung transplantation—an emerging concept

Clinical transplantation tolerance

Loss of tolerance to self after transplant

Lung transplantation: infection, inflammation, and the microbiome

Steroids in kidney transplant patients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials